To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

US Army issues CD&RR Phase 2 contracts for FLRAA

31st March 2021 - 17:28 GMT | by The Shephard News Team

RSS

The V-280 Valor tiltrotor aircraft is one of the contenders in the Future Long Range Assault Aircraft programme. (Photo: Bell)

Bell Textron and Sikorsky-Boeing will complete Competitive Demonstration and Risk Reduction phase of Future Long Range Assault Aircraft programme by 30 March 2022.

Bell Textron and a Sikorsky-Boeing team have each received Competitive Demonstration and Risk Reduction (CD&RR) Phase 2 contracts for the Future Long Range Assault Aircraft (FLRAA) programme, the US Army Program Executive Office (PEO) Aviation announced on 31 March.

The contract for Bell Textron is worth $292.65 million, while the deal for Sikorsky-Boeing is valued at $284.39 million.

These Other Transaction Authority agreements will require the contractors ‘to complete an initial preliminary design event for major subsystems and the conceptual weapons system’, PEO Aviation added.

CDRR covers conceptual designs and trade studies with model-based systems engineering. It supports ‘preliminary analysis of requirements for Special Operations Command, MEDEVAC and Defense Exportability Features in FLRAA’, according to PEO Aviation.

Bell Textron is offering its V-280 Valor tiltrotor for FLRAA, in competition with the  SB>1 Defiant from Sikorsky.

Both teams will complete CD&RR Phase 2 work by 30 March 2022, and Shephard understands that PEO Aviation will declare a winner in the summer of that year.

As part of our promise to deliver comprehensive coverage to our Defence Insight and Premium News subscribers, our curated defence news content provides the latest industry updates, contract awards and programme milestones.

The Shephard News Team

Author

The Shephard News Team


As part of our promise to deliver comprehensive coverage to Premium News and Defence Insight …

Read full bio

Share to

Linkedin